GORMAN KEVIN CHARLES

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$1,013.36
Insider Sells Quantity
59
Insider Sells Sum
$109.08M

Insider Activity of GORMAN KEVIN CHARLES

According to the SEC Form 4 filings, GORMAN KEVIN CHARLES, being in a position of

  1. Chief Executive Officer at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 178711 share for $23.82M,
    over all time since 2004-02-10, has bought 0 shares, and sold 1579558 shares for $109.02M.

The largest purchase of all time was on 2024-02-13 and amounted to 53 shares of Xencor, Inc. for $1,013.

The largest sale of all time was on 2021-01-08 and amounted to 308250 shares of Neurocrine Biosciences, Inc. for $33.97M.

Biography of GORMAN KEVIN CHARLES

No biography is available at this moment.

2024-09-27SaleXencor, Inc.
XNCR
director
2,654
0.0038%
$20.68$54,885+3.8%
2024-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,832
0.0029%
$133.02$376,700+1.39%
2024-02-13PurchaseXencor, Inc.
XNCR
director
53
<0.0001%
$19.12$1,013+11.04%
2024-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0022%
$134.15$305,052+0.77%
2024-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,040
0.0031%
$142.18$432,218-5.25%
2024-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,707
0.0027%
$140.69$380,845-2.82%
2024-01-09SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
62,023
0.0632%
$134.01$8.31M+1.69%
2024-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
105,835
0.1071%
$132.44$14.02M+1.88%
2023-08-21SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
9,328
0.0095%
$107.40$1M+23.1%
2023-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0023%
$104.30$237,185+0.32%
2023-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
23,730
0.0241%
$102.42$2.43M+0.86%
2023-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,040
0.0032%
$105.68$321,259-0.39%
2023-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,707
0.0028%
$110.08$297,997-5.7%
2022-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0024%
$79.49$180,768+28.58%
2022-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
8,710
0.0091%
$80.82$703,907+26.82%
2021-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
10,466
0.011%
$116.75$1.22M-19.67%
2021-02-05SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,422
0.0025%
$114.16$276,504-18.56%
2021-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
308,250
0.3218%
$110.22$33.97M-14.99%
2020-11-12SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,390
0.0036%
$90.78$307,748+6.08%
2020-08-05SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,390
0.0036%
$118.91$403,101-17.85%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.